Century Therapeutics Inc (IPSC) — Cash Flow Quality Index
Latest as of March 2025:
-0.45x
Century Therapeutics Inc (IPSC) has a Cash Flow Quality Index of -0.45x as of March 2025. Operating cash flow of $-34.62 Million is below net income of $76.56 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how much of Century Therapeutics Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
-0.45x
Operating CF / Net Income
Operating Cash Flow
$-34.62 Million
USD
Net Income
$76.56 Million
USD
Data as of
Mar 2025
Most recent filing
Annual Cash Flow Quality Index for Century Therapeutics Inc (None–None)
Year-by-year earnings quality comparison for Century Therapeutics Inc. For live market cap and the full company financial profile, see how much is Century Therapeutics Inc worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.